170 related articles for article (PubMed ID: 8926079)
21.
Cardenas AJ; Thomas KS; Broden MW; Ferraro NJ; John CM; Pires MM; Jarvis GA; Criss AK
bioRxiv; 2024 Jan; ():. PubMed ID: 38293026
[TBL] [Abstract][Full Text] [Related]
22. The surface structure seen on gonococci after treatment with CMP-NANA is due to sialylation of surface lipopolysaccharide previously described as a 'capsule'.
Fox AJ; Curry A; Jones DM; Demarco de Hormaeche R; Parsons NJ; Cole JA; Smith H
Microb Pathog; 1991 Sep; 11(3):199-210. PubMed ID: 1724790
[TBL] [Abstract][Full Text] [Related]
23. Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis.
Kim JJ; Zhou D; Mandrell RE; Griffiss JM
Infect Immun; 1992 Oct; 60(10):4439-42. PubMed ID: 1398958
[TBL] [Abstract][Full Text] [Related]
24. Incorporation of N-acetylneuraminic acid into Haemophilus somnus lipooligosaccharide (LOS): enhancement of resistance to serum and reduction of LOS antibody binding.
Inzana TJ; Glindemann G; Cox AD; Wakarchuk W; Howard MD
Infect Immun; 2002 Sep; 70(9):4870-9. PubMed ID: 12183531
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic CMP-Nonulosonates against Multidrug-Resistant
Gulati S; Schoenhofen IC; Lindhout-Djukic T; Schur MJ; Landig CS; Saha S; Deng L; Lewis LA; Zheng B; Varki A; Ram S
J Immunol; 2020 Jun; 204(12):3283-3295. PubMed ID: 32434942
[No Abstract] [Full Text] [Related]
26. Epitope expression and partial structural characterization of F62 lipooligosaccharide (LOS) of Neisseria gonorrhoeae: IgM monoclonal antibodies (3F11 and 1-1-M) recognize non-reducing termini of the LOS components.
Yamasaki R; Nasholds W; Schneider H; Apicella MA
Mol Immunol; 1991 Nov; 28(11):1233-42. PubMed ID: 1720505
[TBL] [Abstract][Full Text] [Related]
27. Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid.
Parsons NJ; Andrade JR; Patel PV; Cole JA; Smith H
Microb Pathog; 1989 Jul; 7(1):63-72. PubMed ID: 2509853
[TBL] [Abstract][Full Text] [Related]
28. Role of lipooligosaccharide in Opa-independent invasion of Neisseria gonorrhoeae into human epithelial cells.
Song W; Ma L; Chen R; Stein DC
J Exp Med; 2000 Mar; 191(6):949-60. PubMed ID: 10727457
[TBL] [Abstract][Full Text] [Related]
29. Identification by mass spectrometry of CMP-NANA in diffusible material released from high M(r) blood cell fractions that confers serum resistance on gonococci.
Parsons NJ; Ashton PR; Constantinidou C; Cole JA; Smith H
Microb Pathog; 1993 Apr; 14(4):329-35. PubMed ID: 8326856
[TBL] [Abstract][Full Text] [Related]
30. Physiology of sialic acid capsular polysaccharide synthesis in serogroup B Neisseria meningitidis.
Masson L; Holbein BE
J Bacteriol; 1983 May; 154(2):728-36. PubMed ID: 6302082
[TBL] [Abstract][Full Text] [Related]
31. Alpha-2,3-sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection.
Wu H; Jerse AE
Infect Immun; 2006 Jul; 74(7):4094-103. PubMed ID: 16790783
[TBL] [Abstract][Full Text] [Related]
32. Neisseria gonorrhoeae LPS variation, serum resistance and its induction by cytidine 5'-monophospho-N-acetylneuraminic acid.
Demarco de Hormaeche R; van Crevel R; Hormaeche CE
Microb Pathog; 1991 Apr; 10(4):323-32. PubMed ID: 1716719
[TBL] [Abstract][Full Text] [Related]
33. Lactic acid is the factor in blood cell extracts which enhances the ability of CMP-NANA to sialylate gonococcal lipopolysaccharide and induce serum resistance.
Parsons NJ; Boons GJ; Ashton PR; Redfern PD; Quirk P; Gao Y; Constantinidou C; Patel J; Bramley J; Cole JA; Smith H
Microb Pathog; 1996 Feb; 20(2):87-100. PubMed ID: 8722097
[TBL] [Abstract][Full Text] [Related]
34. A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.
Ram S; Gulati S; Lewis LA; Chakraborti S; Zheng B; DeOliveira RB; Reed GW; Cox AD; Li J; St Michael F; Stupak J; Su XH; Saha S; Landig CS; Varki A; Rice PA
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29844237
[TBL] [Abstract][Full Text] [Related]
35. Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum.
Nairn CA; Cole JA; Patel PV; Parsons NJ; Fox JE; Smith H
J Gen Microbiol; 1988 Dec; 134(12):3295-306. PubMed ID: 3151997
[TBL] [Abstract][Full Text] [Related]
36. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS.
Mandrell RE; Apicella MA
Immunobiology; 1993 Apr; 187(3-5):382-402. PubMed ID: 8330904
[TBL] [Abstract][Full Text] [Related]
37. Lipooligosaccharide biosynthesis in pathogenic Neisseria. Cloning, identification, and characterization of the phosphoglucomutase gene.
Zhou D; Stephens DS; Gibson BW; Engstrom JJ; McAllister CF; Lee FK; Apicella MA
J Biol Chem; 1994 Apr; 269(15):11162-9. PubMed ID: 8157643
[TBL] [Abstract][Full Text] [Related]
38. Uptake of metabolites by gonococci grown with lactate in a medium containing glucose: evidence for a surface location of the sialyltransferase.
Gao L; Linden L; Parsons NJ; Cole JA; Smith H
Microb Pathog; 2000 May; 28(5):257-66. PubMed ID: 10799276
[TBL] [Abstract][Full Text] [Related]
39. Sialylation of lipopolysaccharide by CMP-NANA in viable gonococci is enhanced by low Mr material released from blood cell extracts but not by some UDP sugars.
Parsons NJ; Constantinidou C; Cole JA; Smith H
Microb Pathog; 1994 Jun; 16(6):413-21. PubMed ID: 7830528
[TBL] [Abstract][Full Text] [Related]
40. Cloning of the lipooligosaccharide alpha-2,3-sialyltransferase from the bacterial pathogens Neisseria meningitidis and Neisseria gonorrhoeae.
Gilbert M; Watson DC; Cunningham AM; Jennings MP; Young NM; Wakarchuk WW
J Biol Chem; 1996 Nov; 271(45):28271-6. PubMed ID: 8910446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
